June 2017 FDA Recall Ibuprofen by Time-cap Laboratories, Inc.
D-1055-2017 - Presence of foreign tablets/capsules

This Class II drug recall was voluntarily initiated by Time-cap Laboratories, Inc. on June 16, 2017 for the product Ibuprofen. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1055-2017

Reason for Recall
Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.
Initiated
06-16-2017
Reported
08-09-2017
Quantity
1,980 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Time-Cap Laboratories, Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured for: Time Cap Labs, Inc., 7 Michael Avenue Farmingdale, NJ 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate, Verna, Goa-403 722, India, NDC 49483-603-50

Batch or Lot Expiration Information

Lot# : HN7003